TB and COPD linked: researchers


TB and COPD link: lungs highlighted in orange

Australian scientists have shown an important link between two, previously unconnected lung diseases: TB and COPD.

While COPD has long been considered a smoker’s disease, 30% of cases have never smoked.

The Woolcock researchers scanned international scientific literature for a link between the two conditions. The results, released ahead of World TB Day on March 24, leave no doubt the diseases are intimately connected.

“We found that people who have had TB are three times more likely to get chronic obstructive pulmonary disease or another respiratory disease called bronchiectasis,” says Professor Guy Marks, Woolcock respiratory physician and supervisor of the research published in the International Journal of Infectious Diseases.

Non-smokers, young people and people from countries with higher rates of tuberculosis appear to have an even higher risk of developing chronic respiratory disease following tuberculosis, the research shows.

“We have long known that TB is an important cause of illness and death in many countries around the world. However, in the past we have tended to believe that those who recover from TB do not have longer terms problems.

“Our findings call this into question by highlighting the serious long-term consequences of TB. COPD is already a high burden disease around the world. This link between TB and COPD provides another reason to focus attention the need to combat TB globally,” Dr Marks says.

The link was found by PhD student Dr Anthony Byrne who led a systematic literature review of 11 studies that included both TB and lung disease data.

The studies included Australian sites, and other population data collected in South Africa, Latin America and Asia.

“With so many Australians born overseas in these tuberculosis endemic regions, these findings may have important implications for Australian clinicians and researchers,” Dr Byrne says.

Armed with these findings, the researcher and his team are now studying the specific effects of tuberculosis on lung function in 400 people in Lima, Peru, to better understand the link between the conditions.

“My study will be the first population-based research designed to test the association between lung function, as well as allergy and asthma, and a past history of known tuberculosis infection,” he says.

Tuberculosis research is a key focus for the Woolcock. The leading research institute is collaborating with the Centenary Institute to increase awareness of TB’s impact on people’s lives and to improve health outcomes faster through collaboration in research.

The new research, Tuberculosis and Chronic Respiratory Disease: A Systematic Review, is published in the online journal on March 23.

It was completed in partnership with The University of Sydney, The Centre for Research Excellence in Tuberculosis, Marie Bashir Institute for Infectious Diseases and Biosecurity, Socios En Salud Sucursal, Lima, Perú and Harvard Medical School, Boston, USA.

Previous RACGP demands real-time prescription drug database
Next NSW Labor promises 24-hour pharmacy trial

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.